REQUEST A DEMO
Total
USD $0.00
Search more companies

GlaxoSmithKline Eesti OU (Estonia)

Main Activities: All Other Professional, Scientific, and Technical Services
Full name: GlaxoSmithKline Eesti OU Profile Updated: May 18, 2022
Buy our report for this company USD 19.99 Most recent financial data: 2021 Available in: English & Russian Download a sample report

GlaxoSmithKline Eesti OU is an enterprise in Estonia, with the main office in Tallinn. It operates in the All Other Professional, Scientific, and Technical Services industry. The company was established on September 17, 1997. It currently has a total number of 6 - 10 (2021) employees. From the latest financial highlights, GlaxoSmithKline Eesti OU reported a net sales revenue drop of 61.03% in 2021. Its total assets decreased by 25.89% over the same period. The enterprise’s net profit margin increased by 1.21% in 2021.

Headquarters
Lootsa tn 8a
Tallinn; Harju county; Postal Code: 11415

Contact Details: Purchase the GlaxoSmithKline Eesti OU report to view the information.

Website: http://www.gsk.ee

Basic Information
Total Employees:
Purchase the GlaxoSmithKline Eesti OU report to view the information.
Outstanding Shares:
Purchase the GlaxoSmithKline Eesti OU report to view the information.
Registered Capital:
Purchase the GlaxoSmithKline Eesti OU report to view the information.
Incorporation Date:
September 17, 1997
Key Executives
Purchase this report to view the information.
Member of Management Board
Company Performance
Financial values in the chart are available after GlaxoSmithKline Eesti OU report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
-61.03%
Total operating revenue
-61.04%
Operating profit (EBIT)
-48.77%
Net Profit (Loss) for the Period
-45.07%
Total assets
-25.89%
Total equity
9.64%
Operating Profit Margin (ROS)
1.02%
Net Profit Margin
1.21%
Return on Equity (ROE)
-8.76%
Cash Ratio
1.14%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?